Slopak, I don't think there will be anymore share consolidation because the Research&Development and extensive adverisement in the media in the past few years have ended, the $355 million spent had to come from equity financing, without equity financing, the company could not continue to operate. Since financiers do not like share dilution, so share consolidation must be implemented just as happening among other junior venturers in mining and in biopharmaceutical industry. Subtle investors would have exited before share consolidation only the inexperienced and inflexible investors would hold on to a major downtrend. But in every adversity emeges opportunities, if those investors are still have faith in the company' future, they should be jumping for joy and load up at these dirt cheap prices and in the long run they will incur much more gain, may be be a future millionaire. Annual sales is rising toward the management's near term goal of $10 million while operating expenses are being reduced, as a result, positive earnings will be achieved and there will no need for futher share consolidation to obtain working capital. When share price rises above the Exchnage's required minimum level, ASTI wll be back in the main board of NASDAQ. So think positively ..... be happy. I think it is insane for investors to engage in dog fight at share price around 2 cents, looking ahead a couple of years, any price now under 10 cents is a steal.
News 
Market Data 
Discover 
